Suchergebnisse

Recent years have seen significant advances in the science of using antiretroviral medicines (ARVs) to fight HIV. Where not long ago ARVs were used late in disease to prevent sick people from dying, today people living with HIV can use ARVs to achieve viral suppression early in the course of disease. This article reviews the mounting new scientific evidence of major clinical and prevention ARV benefits. This has changed the logic of the AIDS response, eliminating competition between 'treatment' and 'prevention' and encouraging early initiation of treatment for individual and public health benefit. These breakthroughs have implications for the health-related human rights duties of States. With medical advance, the 'highest attainable standard' of health has taken a leap, and with it the rights obligations of States. We argue that access to early treatment for all is now a core State obligation and restricting access to, or failing to provide accurate information about, it violates both individual and collective rights. In a context of real political and technical challenges, however, in this article we review the policy implications of evolving human rights obligations given the new science. National and international legal standards require action on budget, health and intellectual property policy, which we outline. Adapted from the source document.

With more than 40 million people living with HIV/AIDS—and more than 25 million dead from related diseases since the early 1980s—the need to understand the causes and impact of the pandemic is manifest. In response, The Global Politics of AIDS explores power and politics at multiple levels, ranging from individual behavior to corporate boardrooms to international institutions and forces. The authors combine careful scholarship with sensitivity to both the suffering of those afflicted and the frustration of those seeking to bring about meaningful change. All royalties from sales of the book will be donated to AIDS-related charities